BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 20, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
SKB reports calcium antagonists for stroke
April 19, 1996
New Takeda compounds suppress increased vascular permeability
April 19, 1996
Lilly reports cannabinoid receptor antagonists
April 19, 1996
Dolasetron submitted for approval in U.S.
April 19, 1996
Cerebyx approvable in USA
April 19, 1996
Myotrophin NDA submission on track
April 19, 1996
GP-3269, new AK inhibitor from Gensia
April 19, 1996
New dopamine D3 ligand from Warner-Lambert
April 19, 1996
P&U's U-99363E shows high affinity for D4 receptors
April 19, 1996
BASF reports dopamine D3 ligands
April 19, 1996
Previous
1
2
…
2740
2741
2742
2743
2744
2745
2746
2747
2748
2749
2750
Next
RSS